Green Thumb Industries (GTBIF) Current Assets (2019 - 2026)
Green Thumb Industries (GTBIF) posted Current Assets of $673.8 million for Q1 2026, up 16.75% on a QoQ basis from $577.2 million in Q4 2025, and up 51.46% year-over-year from $444.9 million in Q1 2025.
Green Thumb Industries (GTBIF) Current Assets (2019 - 2026) Analysis & Trends
Green Thumb Industries' Current Assets history runs 8 years deep, the most recent figure standing at $673.8 million for Q1 2026.
- Quarterly Current Assets rose 51.46% year-over-year to $673.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $673.8 million (up 51.46% YoY) and the FY2025 annual result came in at $577.2 million, up 42.9% from the prior year.
- Current Assets was $673.8 million for Q1 2026 at Green Thumb Industries, up from $577.2 million in the prior quarter.
- Across five years, Current Assets topped out at $673.8 million in Q1 2026 and bottomed at $311.5 million in Q2 2022.
- A 5-year average of $404.1 million and a median of $391.9 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets sank 35.32% — and 2026, when it surged 51.46%.
- Green Thumb Industries' Current Assets stood at $351.4 million in 2022, then fell by 2.44% to $342.8 million in 2023, then gained by 17.84% to $403.9 million in 2024, then surged by 42.9% to $577.2 million in 2025, then rose by 16.75% to $673.8 million in 2026.
- Business Quant data shows GTBIF's Current Assets at $673.8 million in Q1 2026, $577.2 million in Q4 2025, and $477.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 673.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 673.85 Mn |
| Dec 31, 2025 | 577.17 Mn |
| Sep 30, 2025 | 477.46 Mn |
| Jun 30, 2025 | 405.44 Mn |
| Mar 31, 2025 | 444.91 Mn |
| Dec 31, 2024 | 403.90 Mn |
| Sep 30, 2024 | 391.87 Mn |
| Jun 30, 2024 | 403.80 Mn |
| Mar 31, 2024 | 419.69 Mn |
| Dec 31, 2023 | 342.76 Mn |
| Sep 30, 2023 | 320.18 Mn |
| Jun 30, 2023 | 341.25 Mn |
| Mar 31, 2023 | 357.61 Mn |
| Dec 31, 2022 | 351.35 Mn |
| Sep 30, 2022 | 318.56 Mn |
| Jun 30, 2022 | 311.53 Mn |
| Mar 31, 2022 | 328.36 Mn |
| Dec 31, 2021 | 364.23 Mn |
| Sep 30, 2021 | 420.75 Mn |
| Jun 30, 2021 | 481.62 Mn |